Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is associated with faster viral clearance and COVID-19 symptom resolution
View ORCID ProfileNora Pisanic, Annukka A. R. Antar, Marissa K. Hetrich, Zoe O. Demko, Xueyan Zhang, Kristoffer Spicer, Kate L. Kruczynski, Barbara Detrick, William Clarke, Maria Deloria Knoll, David L. Thomas, Fatimah S. Dawood, Vic Veguilla, Ruth A. Karron, Yukari C. Manabe, View ORCID ProfileChristopher D. Heaney
doi: https://doi.org/10.1101/2024.02.21.24303146
Nora Pisanic
1Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
Annukka A. R. Antar
2Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
Marissa K. Hetrich
3Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
Zoe O. Demko
2Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
Xueyan Zhang
3Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
Kristoffer Spicer
1Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
Kate L. Kruczynski
1Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
Barbara Detrick
4Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
William Clarke
4Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
Maria Deloria Knoll
3Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
David L. Thomas
2Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
4Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
Fatimah S. Dawood
5COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Vic Veguilla
5COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Ruth A. Karron
3Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
Yukari C. Manabe
2Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA
3Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
7Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
Christopher D. Heaney
1Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
3Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
6Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
Data Availability
All data produced in the present study are available upon reasonable request to the authors after consultation with and approval of all study PIs.
Posted February 23, 2024.
Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is associated with faster viral clearance and COVID-19 symptom resolution
Nora Pisanic, Annukka A. R. Antar, Marissa K. Hetrich, Zoe O. Demko, Xueyan Zhang, Kristoffer Spicer, Kate L. Kruczynski, Barbara Detrick, William Clarke, Maria Deloria Knoll, David L. Thomas, Fatimah S. Dawood, Vic Veguilla, Ruth A. Karron, Yukari C. Manabe, Christopher D. Heaney
medRxiv 2024.02.21.24303146; doi: https://doi.org/10.1101/2024.02.21.24303146
Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is associated with faster viral clearance and COVID-19 symptom resolution
Nora Pisanic, Annukka A. R. Antar, Marissa K. Hetrich, Zoe O. Demko, Xueyan Zhang, Kristoffer Spicer, Kate L. Kruczynski, Barbara Detrick, William Clarke, Maria Deloria Knoll, David L. Thomas, Fatimah S. Dawood, Vic Veguilla, Ruth A. Karron, Yukari C. Manabe, Christopher D. Heaney
medRxiv 2024.02.21.24303146; doi: https://doi.org/10.1101/2024.02.21.24303146
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)